about
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryComparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin.Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study.DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation.Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin.Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects.Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
P2860
Q26742078-C1C9F52B-68C7-4C41-877F-B24434C38BD4Q34309915-D1AE5825-FD05-47AD-AECB-926FA3B27CD2Q35932794-A323ADD5-6D2A-4503-A116-4C1D22F46496Q38121955-BA56655E-1744-4F4B-AED1-427ED914AA47Q38795441-ED22796E-27DF-41F0-A38D-637A650672B4Q38799444-C1C46500-63C0-4B9D-8E08-E5B490CD47DBQ38870220-9987FC79-CA9A-4E27-B4A5-D1304212B46DQ41212195-190736BC-0610-4763-94F3-7EA66189F568Q42809333-DE8D6652-2FBA-4A2C-8006-86BAAC71C32BQ46569102-1BA65BCA-9F94-444A-B3F0-CF576BC9BEA0Q59229081-CB5018D0-10DF-4098-A956-7CEFC997F70B
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Clinical and pharmacokinetic evaluation of satraplatin.
@en
Clinical and pharmacokinetic evaluation of satraplatin.
@nl
type
label
Clinical and pharmacokinetic evaluation of satraplatin.
@en
Clinical and pharmacokinetic evaluation of satraplatin.
@nl
prefLabel
Clinical and pharmacokinetic evaluation of satraplatin.
@en
Clinical and pharmacokinetic evaluation of satraplatin.
@nl
P2093
P2860
P1476
Clinical and pharmacokinetic evaluation of satraplatin.
@en
P2093
Cora N Sternberg
Guru Sonpavde
Gury Doshi
P2860
P304
P356
10.1517/17425255.2012.636352
P407
P577
2011-11-19T00:00:00Z